Erythromycin
Treatment for Chlamydial Infection
Typical Dosage: 500mg orally four times daily for 7 days or 250mg orally four times daily for 14 days
Effectiveness
85%
Safety Score
68%
Clinical Trials
39
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
500mg orally four times daily for 7 days or 250mg orally four times daily for 14 days
Time to Effect
7-14 days for cure
Treatment Duration
7-14 days
Evidence Quality
MODERATENumber Needed to Treat (NNT)
1.18(Treat 1.18 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$600
Side Effect Mgmt:$30
Total Annual:$660
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEQALYs Gained
0.06
Outcome-Based Costs
Cost per Responder
$70.59
Cost per Remission
$70.59
Comparison vs Doxycycline
Cost Difference
+$35/year
More expensive
QALY Difference
-0.02 QALYs
Worse outcomes
Dominance
No dominance
Erythromycin Outcomes
for Chlamydial Infection
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+85%
Common Side Effects
Nausea
+25%
Vomiting
+20%
Abdominal pain
+15%
Diarrhea
+15%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
16 completed trials for Erythromycin in Chlamydial Infection
Treatment of Antenatal Chlamydia Infection
NCT01946256COMPLETEDPHASE2
220 participants
INTERVENTIONAL
Ile-Ife, Nigeria
Started: Oct 1, 2013
Clinical Trial of Eye Prophylaxis in the Newborn
NCT00000120COMPLETEDPHASE3
INTERVENTIONAL
Started: Jan 1, 1985
YCFM (Youth Correctional Facilities Males)
NCT03249935COMPLETEDPHASE2
100 participants
INTERVENTIONAL
Los Angeles, United States
Started: Aug 24, 2017
Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities
NCT00980148COMPLETEDPHASE3
567 participants
INTERVENTIONAL
Birmingham, United States +1 more
Started: Dec 1, 2009
Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM
NCT03608774COMPLETEDPHASE4
177 participants
INTERVENTIONAL
Boston, United States +1 more
Started: Jul 13, 2018
The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis
NCT01178762COMPLETEDNA
42 participants
INTERVENTIONAL
Taipei, Taiwan
Started: Sep 1, 2007
Chlamydia Trachomatis Immunology and Vaccinology Study
NCT01150747COMPLETED
347 participants
OBSERVATIONAL
Pittsburgh, United States +3 more
Started: Jan 1, 2011
Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women
NCT01631201COMPLETEDPHASE2
82 participants
INTERVENTIONAL
Birmingham, United States +4 more
Started: Jul 1, 2012
Tripartite International Research for the Elimination of Trachoma
NCT01202331COMPLETEDPHASE4
29K participants
INTERVENTIONAL
Addis Ababa, Ethiopia
Started: Nov 1, 2010
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
NCT00618449COMPLETEDPHASE4
1.14K participants
INTERVENTIONAL
San Francisco, United States +1 more
Started: Jan 1, 2008
Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT
NCT03862495COMPLETEDNA
200 participants
INTERVENTIONAL
Guangzhou, China +1 more
Started: May 21, 2020
Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers
NCT01329588COMPLETEDPHASE4
636 participants
INTERVENTIONAL
Cotonou, Benin
Started: Mar 1, 2001
Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
NCT00043264COMPLETEDPHASE2
40 participants
INTERVENTIONAL
Houston, United States
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
NCT00351273COMPLETEDPHASE3
42 participants
INTERVENTIONAL
Tampa, United States +2 more
Started: May 1, 2006
Microorganism in Overactive Bladder Patients
NCT00883818COMPLETEDPHASE4
84 participants
INTERVENTIONAL
Inchon, South Korea +2 more
Started: Jan 1, 2007
Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea
NCT02210325COMPLETEDPHASE3
264 participants
INTERVENTIONAL
Baltimore, United States +4 more
Started: Aug 1, 2014
Showing 20 of 39 total trials